Inventor · disambiguated record
Gary Harold Birnberg
Also filed as: BIRNBERG GARY H · BIRNBERG GARY HAROLD
17 granted patents·5 pending applications·230 citations·filing 1980–2009
94Inventor score
Top patents by PatentIndex Score
22 records- 0192US4299769Aω-Heteroaroyl(propionyl or butyryl)-L-prolinesAMERICAN CYANAMID CO·Filed 1980·Granted Nov 10, 1981·28 cites·7 claims
- 0289US7713994B2Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereofWYETH LLC·Filed 2007·Granted May 11, 2010·27 cites·18 claims
- 0389US7626023B2Compounds for treating tumorsWYETH CORP·Filed 2008·Granted Dec 1, 2009·12 cites·13 claims
- 0485US7390910B2Compounds for treating tumorsWYETH CORP·Filed 2004·Granted Jun 24, 2008·14 cites·45 claims
- 0581US5482971ABeta3 -adrenergic agents and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1993·Granted Jan 9, 1996·24 cites·17 claims
- 0681US4977189ASubstituted guanidinedicarbonyl derivativesAMERICAN CYANAMID CO·Filed 1988·Granted Dec 11, 1990·18 cites·17 claims
- 0778US5594027AAminocycloalkanobenzodioxoles as beta-3 selective adrenergic agentsAMERICAN CYANAMID CO·Filed 1995·Granted Jan 14, 1997·21 cites·48 claims
- 0878US5480908Aβ3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1993·Granted Jan 2, 1996·16 cites·6 claims
- 0975US4342689Aω-Heteroaroyl(propionyl or butyryl)-L-prolinesAMERICAN CYANAMID CO·Filed 1981·Granted Aug 3, 1982·9 cites·10 claims
- 1072US5968908ARestricted 9-cis retinoidsAMERICAN CYANAMID CO·Filed 1995·Granted Oct 19, 1999·15 cites·33 claims
- 1172US5510376AAminocycloalkanobenzodioxoles as beta-3 selective adrenergic agentsAMERICAN CYANAMID CO·Filed 1994·Granted Apr 23, 1996·24 cites·21 claims
- 1271US4342691Aω-Heteroaroyl(propionyl or butyryl)-L-prolinesAMERICAN CYANAMID CO·Filed 1981·Granted Aug 3, 1982·7 cites·10 claims
- 1371US4342690Aω-Heteroaroyl(propionyl or butyryl)-L-prolinesAMERICAN CYANAMID CO·Filed 1981·Granted Aug 3, 1982·7 cites·10 claims
- 1468US6784184B25-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted Aug 31, 2004·4 cites·36 claims
- 1558US2008171874A1Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolinesWYETH CORP·Filed 2008·Application pending·0 cites
- 1651US5606069Aβ3 -adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1995·Granted Feb 25, 1997·4 cites·2 claims
- 1749US7365197B2Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolinesWYETH CORP·Filed 2001·Granted Apr 29, 2008·0 cites·7 claims
- 1849US2002091273A1Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolinesAMERICAN HOME PROD·Filed 2002·Application pending·0 cites
- 1949US2010068204A14-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agentsWYETH CORP·Filed 2009·Application pending·0 cites
- 2048US2009298820A13-substituted-1h-pyrrolo[2,3-b]pyridine and 3-substituted-1h-pyrrolo[3,2-b]pyridine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 2148US2009311217A13-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 2245US6605628B1Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted Aug 12, 2003·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Gary Harold Birnberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →